Biodexa Pharmaceuticals Plc
February 10, 2025 - by Joey Ramson
$BDRX is leading the Prism MarketView Pharmaceuticals index. The company released this morning that it has received US FDA Fast Track Designation for eRapa in Familial Adenomatous Polyposis
